Patents expiring in 2029

US 7582765

Aryl aniline β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582425

Atlastin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582430

Immunoliposome-nucleic acid amplification (ILNAA) assay

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7581846

Dental light devices having an improved heat sink

DISCUS DENTAL, LLC · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7581864

Tooth bleaching process

DISCUS DENTAL, LLC · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582279

Blood-pool carrier for lipophilic imaging agents

The Board of Regents of the University of Michigan · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582284

Particulate materials

Nektar Therapeutics · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582298

High affinity antibodies to human IL-6 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582312

Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof

Discovery Laboratories, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582307

Dermatological composition

Harmony Labs, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582442

Methods and compositions for using aleveolar macrophage phospholipase A2

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582648

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582623

Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

The Regents of the University of California · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582641

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582680

Methods and compositions for treating mammalian spinal cord injuries

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582745

Compositions and methods for inhibiting expression of Nav1.8 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582759

Diastereomeric purification of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585841

Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585667

Negative strand RNA virus replicon

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585880

Phenylpropanoic acid derivatives

Takeda Pharmaceutical Company Limited · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585879

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585844

Myosin light chain kinase inhibitors and methods of use

University College Cardiff Consultants Limited · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585842

Human kunitz-type inhibitor with enhanced antifibrinolytic activity

The Regents of the University of California · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585520

Compositions containing both sedative and non-sedative antihistamines and sleep aids

Collegium Pharmaceutical, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585883

Substituted pyridines and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585868

Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists

The Regents of the University of California · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585852

Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation

Solidago AG · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585877

Aminophenyl derivatives as selective androgen receptor modulators

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585622

Increasing the proliferative capacity of cells using telomerase reverse transcriptase

The Regents of the University of Colorado · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7585653

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Theravance, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7589100

Non-hygroscopic and powdery amorphous pimecrolimus

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7589075

Use of an adenosine A3 receptor agonist for inhibition of viral replication

CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7589214

Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7589220

Inhibitors of the anandamide transporter

UNIVERSITY OF CONNECTICUT · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7589200

5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7589181

Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7589157

Multi-arm block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7588912

Compositions and methods for preventing and treating anthrax diseases

The Regents of the University of California · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7588703

Microencapsulation system and method

United States of America as represented by the Administrator of NASA · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7592322

RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7591995

Cobalamin conjugates useful as imaging and therapeutic agents

Regents of the University of Minnesota · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7592016

Methods for preparing and using implantable substance delivery devices

The Regents of the University of California · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7592453

Fused quinoline derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7592340

Quinoxalines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7592368

Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7592343

Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

Xenon Pharmaceuticals Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7592355

Quinolinone-carboxamide compounds as 5-HT, receptor agonists

Theravance, Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7595431

Mouse models of human prostate cancer

The Regents of the University of California · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)